Table 4.
Baseline characteristics of virological failures (n = 76).
| Parameter | Relapsed (n = 20) | Nonresponder (n = 56) | P value |
|---|---|---|---|
| Age (y), M ± SD | 61.2 ± 10.2 | 57 ± 18.6 | |
| Male, n (%) | 7 (35) | 23 (41) | |
| BMI >30, n (%) | 6 (30) | 16 (29) | 0.01 |
| Treatment experienced, n (%) | 13 (65) | 33 (59) | |
| Cirrhosis, n (%) | 17 (85) | 27 (48) | |
| Treatment arm | 0.01 | ||
| SOF/DCV, n (%) | 14 (70) | 40 (71.4) | |
| SOF/VEL, n (%) | 6 (30) | 16 (28.6) | |
| Laboratory data | |||
| HB (g/dl) M ± SD | 13.1 ± 1.6 | 13.0 ± 2 | |
| WBCs (×109/L) M ± SD | 7.6 ± 2.6 | 6.8 ± 1.8 | |
| PLT (×109/L) M ± SD | 203 ± 77 | 211 ± 83 | |
| AST (ULN: 40 U/L) M ± SD | 69.9 ± 34.2 | 68.9 ± 36.3 | |
| ALT (ULN: 40 U/L) M ± SD | 87.32 ± 68.4 | 88.2 ± 68.5 | |
| Albumin (g/L) M ± SD | 39.6 ± 3.5 | 39.8 ± 6.3 | |
| Creatinine (mg/dl) M ± SD | 99.03 ± 25 | 100 ± 26 | |
| INR M ± SD | 1.2 ± 0.1 | 1.1 ± 0.1 | |
| TBR (μmol/L) M ± SD | 9.44 ± 3.4 | 11.29 ± 5.6 | |
| HCV PCR log10 | 6.2 ± 0.3 | 6.4 ± 0.9 | 0.02 |
| Comorbidities | |||
| Diabetes, n (%) | 13 (65) | 10 (18) | |
| Obesity, n (%) | 13 (65) | 10 (18) | |
| Hypertension, n (%) | 20 (100) | 38 (67) | |
| HBsAg, n (%) | 1 (5) | 0 (0.0) | |
| Risk factors | |||
| Blood transfusion, n (%) | 19 (95) | 27 (48) | |
| Surgery, n (%) | 12 (60) | 10 (18) | |
| Tobacco smoking, n (%) | 19 (95) | 13 (13) |
Bold values represent statistical significance.